Literature DB >> 2849300

Ki-1 (CD30) antigen is regularly expressed by tumor cells of embryonal carcinoma.

G Pallesen1, S J Hamilton-Dutoit.   

Abstract

Ki-1 (CD30) antigen expression has been considered to be restricted to hematopoietic tissues including the recently described anaplastic large cell lymphoma and Reed-Sternberg (RS) cells in Hodgkin's disease. Its presence on some activated lymphocytes in non-neoplastic lymphoid tissues has been used as evidence that such cells might represent the physiologic counterpart of RS cells. In this study expression of CD30 antigen in 117 nonhematopoietic tumors was investigated using monoclonal antibody Ber-H2. The antigen was regularly expressed in frozen section (strongly) and paraffin section (less strongly) by embryonal carcinomas (8 of 10 studied) and the embryonal elements of mixed germ cell tumors (4 of 4), but not in other types of germ cell tumors (0 of 11) or nonhematopoietic tumors (0 of 92). Normal adult, neonatal, and fetal testes were negative for CD30 antigen, as were other fetal tissues and placenta. Ki-1 antibody gives similar results in frozen section. These findings have implications for theories suggesting an origin of RS cells from activated lymphocytes. They are also important for determining the diagnostic significance of CD30 positivity in a tumor of unknown origin, and suggest possible new uses for CD30 antibodies in routine diagnostic immunohistology.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2849300      PMCID: PMC1880812     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  4 in total

1.  Leu-M1 antigen in human neoplasms. An immunohistologic study of 400 cases.

Authors:  K Sheibani; H Battifora; J S Burke; H Rappaport
Journal:  Am J Surg Pathol       Date:  1986-04       Impact factor: 6.394

2.  Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.

Authors:  G Pallesen; P C Beverley; E B Lane; M Madsen; D Y Mason; H Stein
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

3.  The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells.

Authors:  H Stein; D Y Mason; J Gerdes; N O'Connor; J Wainscoat; G Pallesen; K Gatter; B Falini; G Delsol; H Lemke
Journal:  Blood       Date:  1985-10       Impact factor: 22.113

4.  Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms.

Authors:  G Delsol; K C Gatter; H Stein; W N Erber; K A Pulford; K Zinne; D Y Mason
Journal:  Lancet       Date:  1984-11-17       Impact factor: 79.321

  4 in total
  26 in total

1.  The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.

Authors:  S Pittaluga; I Wlodarska; K Pulford; E Campo; S W Morris; H Van den Berghe; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

2.  CD antigens as promising tools for the functional analysis of solid tumours.

Authors:  P Möller
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report.

Authors:  F Menestrina; M Lestani; A Scarpa; G Viale; F Bonetti; G Pizzolo; M Chilosi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Granulocytic sarcoma with expression of CD30.

Authors:  M Fickers; P Theunissen
Journal:  J Clin Pathol       Date:  1996-09       Impact factor: 3.411

Review 5.  Targeting CD30 in anaplastic large cell lymphoma.

Authors:  Joseph Vadakara; Barbara Pro
Journal:  Curr Hematol Malig Rep       Date:  2012-12       Impact factor: 3.952

6.  Noninvasive Trafficking of Brentuximab Vedotin and PET Imaging of CD30 in Lung Cancer Murine Models.

Authors:  Lei Kang; Dawei Jiang; Emily B Ehlerding; Todd E Barnhart; Dalong Ni; Jonathan W Engle; Rongfu Wang; Peng Huang; Xiaojie Xu; Weibo Cai
Journal:  Mol Pharm       Date:  2018-03-20       Impact factor: 4.939

7.  CD30 antigen in embryonal carcinoma and embryogenesis and release of the soluble molecule.

Authors:  U Latza; H D Foss; H Dürkop; F Eitelbach; K P Dieckmann; V Loy; M Unger; G Pizzolo; H Stein
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

8.  CD30 expression in malignant vascular tumors and its diagnostic and clinical implications: a study of 146 cases.

Authors:  Meghna Alimchandani; Zeng-Feng Wang; Markku Miettinen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 May-Jun

9.  TRA-1-60+, SSEA-4+, POU5F1+, SOX2+, NANOG+ Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Testes.

Authors:  Marek Malecki; Xenia Tombokan; Mark Anderson; Raf Malecki; Michael Beauchaine
Journal:  J Stem Cell Res Ther       Date:  2013-04-02

Review 10.  Combination cancer immunotherapy and new immunomodulatory targets.

Authors:  Kathleen M Mahoney; Paul D Rennert; Gordon J Freeman
Journal:  Nat Rev Drug Discov       Date:  2015-08       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.